Shilpa Medicare launches ‘Prucalshil’ Orally Disintegrating Strips

21 Dec 2021 Evaluate

Shilpa Medicare has launched PRUCALSHIL (Prucalopride) Orally Disintegrating Strips 1 mg and 2 mg in India, a unique formulation developed for the first time in the World. The company has developed a novel ‘Orally Disintegrating Strip (ODS)’ formulation for Prucalopride and obtained subsequent approval from Drug Control General of India. Prucalopride is used for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.

Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients. Orally Disintegrating Strips have an advantage such as greater dissolution due to large surface area, more patient compliance than oral tablets, no risk of choking & better taste masking etc.

Orally Disintegrating Strips technology is emerging in novel drug delivery formulations. The company has acquired expertise with compliance oriented research for development of novel and safer drug delivery such as oral strips keeping in mind patient convenience.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

526.95 -3.40 (-0.64%)
26-Apr-2024 10:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6212.50
Cipla 1404.05
Zydus Lifesciences 953.10
Lupin 1607.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.